Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Sarcoma, Ewing × Methotrexate × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Recurrence 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Leukemia 1 Intraocular Lymphoma 1

Interventions

Vincristine 2 Topotecan 1 Temozolomide 1 Methotrexate 1 Ifosfamide 1 Etoposide 1 Eflornithine 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07321912 2026-01-08

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Milton S. Hershey Medical Center

Phase 2 Not yet recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡